摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-硝基苯甲酰基)吡啶 | 115177-76-9

中文名称
4-(2-硝基苯甲酰基)吡啶
中文别名
——
英文名称
4-(2-nitrobenzoyl)pyridine
英文别名
(2-nitrophenyl)-(4-pyridyl)methanone;(2-nitro-phenyl)-[4]pyridyl ketone;(2-Nitro-phenyl)-[4]pyridyl-keton;(2-nitrophenyl)-pyridin-4-ylmethanone
4-(2-硝基苯甲酰基)吡啶化学式
CAS
115177-76-9
化学式
C12H8N2O3
mdl
——
分子量
228.207
InChiKey
FELKZUPMPWDZKJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    75.8
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] PYRIDINIUM DERIVATIVES AS HERBICIDES<br/>[FR] DÉRIVÉS DE PYRIDINIUM EN TANT QU'HERBICIDES
    申请人:SYNGENTA CROP PROTECTION AG
    公开号:WO2021110890A1
    公开(公告)日:2021-06-10
    Compounds of the formula (I) (I) wherein the substituents are as defined in claim 1, useful as a pesticides, especially as herbicides.
    化合物的化学式(I)(I),其中取代基如权利要求书中所定义,作为杀虫剂特别是除草剂时有用。
  • Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
    申请人:Amgen Inc.
    公开号:US20030096819A1
    公开(公告)日:2003-05-22
    The present invention comprises a new class of novel aryl and heteroaryl substituted fused pyrrole compounds useful for the prophylaxis and treatment of diseases or conditions, such as TNF-&agr;, IL-1&bgr; , IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the prophylaxis and treatment of diseases or conditions involving inflammation. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of inflammation and other maladies, such as pain and diabetes, using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    本发明涉及一类新型的芳基和杂环芳基取代融合吡咯化合物,用于预防和治疗疾病或病症,例如TNF-α,IL-1β,IL-6和/或IL-8介导的疾病,以及其他疾病,如疼痛和糖尿病。特别地,本发明的化合物用于预防和治疗涉及炎症的疾病或病症。因此,本发明还包括包含本发明的化合物的制药组合物,使用本发明的化合物和组合物预防和治疗炎症和其他疾病或病症的方法,以及用于制备本发明化合物的中间体和过程。本发明还涉及制备这种化合物的过程以及在这些过程中有用的中间体。
  • Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
    申请人:Amgen Inc.
    公开号:US06440973B1
    公开(公告)日:2002-08-27
    The present invention comprises a new class of novel aryl and heteroaryl substituted fused pyrrole compounds useful for the prophylaxis and treatment of diseases or conditions, such as TNF-&agr;, IL-1&bgr;, IL-6 and/or IL-8 mediated diseases, and other maladies, such as pain and diabetes. In particular, the compounds of the invention are useful for the prophylaxis and treatment of diseases or conditions involving inflammation. Accordingly, the invention also comprises pharmaceutical compositions comprising the compounds of the invention, methods for the prophylaxis and treatment of inflammation and other maladies, such as pain and diabetes, using the compounds and compositions of the invention, and intermediates and processes useful for the preparation of compounds of the invention. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
    本发明涉及一类新型芳基和杂环芳基取代的融合吡咯化合物,用于预防和治疗疾病或病症,如TNF-α、IL-1β、IL-6和/或IL-8介导的疾病,以及其他疾病,如疼痛和糖尿病。特别地,本发明的化合物对涉及炎症的疾病或病症的预防和治疗有用。因此,本发明还包括包含本发明的化合物的制药组合物、使用本发明的化合物和组合物预防和治疗炎症和其他疾病或病症的方法,以及用于制备本发明的化合物的中间体和过程。该发明还涉及制备这种化合物的过程,以及在这种过程中有用的中间体。
  • Hicks, Martin G.; Jones, Gurnos.; York, David C., Journal of the Chemical Society. Perkin transactions I, 1988, p. 69 - 76
    作者:Hicks, Martin G.、Jones, Gurnos.、York, David C.
    DOI:——
    日期:——
  • HICKS, MARTIN G.;JONES, GURNOS;YORK, DAVID C., J. CHEM. SOC. PERKIN TRANS.,(1988) N 1, 69-75
    作者:HICKS, MARTIN G.、JONES, GURNOS、YORK, DAVID C.
    DOI:——
    日期:——
查看更多